225 related articles for article (PubMed ID: 25398671)
1. Understanding the reasons for delayed referral for intrathecal baclofen therapy in pediatric patients with severe spasticity.
Berman CM; Eppinger MA; Mazzola CA
Childs Nerv Syst; 2015 Mar; 31(3):405-13. PubMed ID: 25398671
[TBL] [Abstract][Full Text] [Related]
2. [Quality of life in cerebral palsy children treated with intrathecal baclofen pump implantation in parents' opinion].
Borowski A; Pruszczyński B; Miller F; Synder M
Chir Narzadow Ruchu Ortop Pol; 2010; 75(5):318-22. PubMed ID: 21853903
[TBL] [Abstract][Full Text] [Related]
3. Long-term intrathecal baclofen: outcomes after more than 10 years of treatment.
Mathur SN; Chu SK; McCormick Z; Chang Chien GC; Marciniak CM
PM R; 2014 Jun; 6(6):506-513.e1. PubMed ID: 24355547
[TBL] [Abstract][Full Text] [Related]
4. Selective dorsal rhizotomy as an alternative to intrathecal baclofen pump replacement in GMFCS grades 4 and 5 children.
Ingale H; Ughratdar I; Muquit S; Moussa AA; Vloeberghs MH
Childs Nerv Syst; 2016 Feb; 32(2):321-5. PubMed ID: 26552383
[TBL] [Abstract][Full Text] [Related]
5. Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore.
Wang ZM; Law JH; King NK; Rajeswaran DK; Soh S; Rao JP; Ng WH; Chua KS
Singapore Med J; 2016 Jan; 57(1):8-12. PubMed ID: 26831310
[TBL] [Abstract][Full Text] [Related]
6. Weight changes in children receiving intrathecal baclofen for the treatment of spasticity.
Pritula SL; Fox MA; Ayyangar R
J Pediatr Rehabil Med; 2012; 5(3):197-201. PubMed ID: 23023252
[TBL] [Abstract][Full Text] [Related]
7. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
Albright AL; Gilmartin R; Swift D; Krach LE; Ivanhoe CB; McLaughlin JF
J Neurosurg; 2003 Feb; 98(2):291-5. PubMed ID: 12593613
[TBL] [Abstract][Full Text] [Related]
8. Positive experience with intrathecal baclofen treatment in children with severe cerebral palsy.
Overgård TM; Kjærsgaard-Hansen L; Søe M; Illum NO
Dan Med J; 2015 Jan; 62(1):A4999. PubMed ID: 25557334
[TBL] [Abstract][Full Text] [Related]
9. [Results of intrathecal baclofen therapy on spasticity in patients with brain injury].
Dénes Z; Klauber A; Both B; Lóránd E
Ideggyogy Sz; 2012 Jul; 65(7-8):243-8; discussion 248. PubMed ID: 23074844
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Dosing of Intrathecal Baclofen in the Treatment of Spasticity After Acquired Brain Injury.
Maneyapanda MB; McCormick ZL; Marciniak C; Reger C
PM R; 2017 Jun; 9(6):556-562. PubMed ID: 28082177
[TBL] [Abstract][Full Text] [Related]
11. Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations.
Turner M; Nguyen HS; Cohen-Gadol AA
J Neurosurg Pediatr; 2012 Oct; 10(4):315-9. PubMed ID: 22861196
[TBL] [Abstract][Full Text] [Related]
12. Long-term intrathecal baclofen therapy in ambulatory patients with spasticity.
Sadiq SA; Wang GC
J Neurol; 2006 May; 253(5):563-9. PubMed ID: 16328111
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
[TBL] [Abstract][Full Text] [Related]
14. [Intrathecal baclofen therapy and management of severe spasticity].
Naito Y
Brain Nerve; 2014 Sep; 66(9):1049-55. PubMed ID: 25200576
[TBL] [Abstract][Full Text] [Related]
15. Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity.
Creamer M; Cloud G; Kossmehl P; Yochelson M; Francisco GE; Ward AB; Wissel J; Zampolini M; Abouihia A; Calabrese A; Saltuari L
Stroke; 2018 Sep; 49(9):2129-2137. PubMed ID: 30354975
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of intrathecal baclofen (ITB) therapy in spacticity.
Ucar T; Kazan S; Turgut U; Samanci NK
Turk Neurosurg; 2011 Jan; 21(1):59-65. PubMed ID: 21294093
[TBL] [Abstract][Full Text] [Related]
17. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).
Baker KW; Tann B; Mutlu A; Gaebler-Spira D
J Child Neurol; 2014 Mar; 29(3):312-7. PubMed ID: 23420651
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.
Natale M; Mirone G; Rotondo M; Moraci A
Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692
[TBL] [Abstract][Full Text] [Related]
19. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity.
Sampson FC; Hayward A; Evans G; Morton R; Collett B
J Neurosurg; 2002 Jun; 96(6):1052-7. PubMed ID: 12066906
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS).
Creamer M; Cloud G; Kossmehl P; Yochelson M; Francisco GE; Ward AB; Wissel J; Zampolini M; Abouihia A; Berthuy N; Calabrese A; Loven M; Saltuari L
J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):642-650. PubMed ID: 29326296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
